FDA
-
-
-
-
-
-
-
Lilly’s Retevmo approved by FDA for RET Tumors
-
-
-
-
-
-
-
Caris Life Sciences to offer PTEN IHC testing for prostate cancer
-
-
-
-
-
-
-
FDA clears Agilent cancer diagnostic for four tumor types
-
-
-
-
-
-
-
TelyRx triples Clearwater headquarters after reaching 1M prescriptions
-
-
-
-
-
-
-
FDA clears Atrium Therapeutics IND for rare heart disease drug
-
-
-
-
-
-
-
Mesoblast reaches 300-patient enrollment in back pain Phase 3 trial
-
-
-
-
-
-
-
FDA sets public hearing on psychedelics for September 14, Jefferies sees FDA willing to move on COMP360
-
325,591 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

